Australia's largest stock trading and investment forum Australia's #1 stock forum

If you have off street parking, just get a pure EV. MG have a...

First 2 Last

Share
Profile

Follow
dave sss

14,069 Posts.

217

26/08/23

21:41

Post #: 69567352
Share

Originally posted by moorookamick: ↑

IMO Hybrids are merely a transition to full EVs with the PHEV in the middle.

While Hybrids and full EVs are making headway in the market
the PHEVs are struggling which, IMO, is all about cost.

The PHEV is almost as expensive as full blown EV with the encumbrance
(some might say benefit) on the ICE. For that reason its hard to see why
a PHEV is cheaper than the equivalent full EV.

At this stage I tend to favour Hybrids and in particular the Toyota Hybrid
simply because Toyota pioneered the Hybrid and up to now has the
lions share of that market.

And my favourite hybrid is the Vitz (here the Yaris Hybrid)
Its small outside but surprisingly roomy in the drivers seat
and for those of us over 6 foot tall, there is no need to break
a neck getting in or out . Of course like all hybrids it has its
ideal position in the market; that of being predominantly a
city car where there is limited opportunity/time for mains battery
recharging and the peace of mind of not being stranded on
that occasional out of town trip.

Here is a pic:

Expand

If you have off street parking, just get a pure EV. MG have a new EV starting at $38k. Charging infrastructure is coming along .... finally
4 Upvote

Reply

Top Stories

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

There are more pages in this discussion • 1,791 more messages in this thread...

First 2 Last

SPONSORED BY